XML 17 R5.htm IDEA: XBRL DOCUMENT v3.25.3
UNAUDITED CONSOLIDATED STATEMENTS MEZZANINE EQUITY AND STOCKHOLDERS' EQUITY - USD ($)
Total
Class A Common Stock
Common Stock
Class A Common Stock
Treasury Stock
Additional Paid-In Capital
Accumulated Deficit
Accumulated Other Comprehensive Income
Non- Controlling Interests
Beginning balance (in shares) at Dec. 31, 2023     63,388,823          
Beginning balance at Dec. 31, 2023 $ 164,070,076   $ 6,339 $ (1,283,062) $ 199,826,278 $ (34,726,135) $ 108,373 $ 138,283
Beginning balance, Treasury stock (in shares) at Dec. 31, 2023       (146,650)        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Deferred transaction costs (483,451)       (483,451)      
Repurchase of common stock (in shares)       (632,116)        
Repurchase of common stock (7,524,392)     $ (7,524,392)        
Stock-based compensation 6,093,371       6,093,371      
Warrant conversions (in shares)     387,235          
Warrant Conversions 4,453,203   $ 39   4,453,164      
Other comprehensive income (loss) 7,436           11,950 (4,514)
Net income (loss) (1,275,471)         (1,348,745)   73,274
Ending balance (in shares) at Mar. 31, 2024     63,776,058          
Ending balance, Treasury stock (in shares) at Mar. 31, 2024       (778,766)        
Ending balance at Mar. 31, 2024 165,340,772   $ 6,378 $ (8,807,454) 209,889,362 (36,074,880) 120,323 207,043
Beginning balance (in shares) at Dec. 31, 2023     63,388,823          
Beginning balance at Dec. 31, 2023 164,070,076   $ 6,339 $ (1,283,062) 199,826,278 (34,726,135) 108,373 138,283
Beginning balance, Treasury stock (in shares) at Dec. 31, 2023       (146,650)        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Other comprehensive loss (111,835)              
Reclassification of change in fair value of debt (risk adjusted) upon related debt payoff 11,079              
Net income (loss) (5,908,533)              
Ending balance (in shares) at Sep. 30, 2024     75,756,439          
Ending balance, Treasury stock (in shares) at Sep. 30, 2024       (1,048,226)        
Ending balance at Sep. 30, 2024 257,939,628   $ 7,576 $ (12,025,137) 309,655,378 (39,639,373) 32,721 (91,537)
Beginning balance (in shares) at Mar. 31, 2024     63,776,058          
Beginning balance at Mar. 31, 2024 165,340,772   $ 6,378 $ (8,807,454) 209,889,362 (36,074,880) 120,323 207,043
Beginning balance, Treasury stock (in shares) at Mar. 31, 2024       (778,766)        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Deferred transaction costs 790,579         790,579    
Common stock sale (in shares)     11,500,000          
Common stock issuance 92,000,000   $ 1,150   91,998,850      
Common stock issuance transaction costs (7,213,627)       (7,213,627)      
Repurchase of common stock (in shares)       (269,460)        
Repurchase of common stock (3,217,683)     $ (3,217,683)        
Stock-based compensation 6,165,459       6,165,459      
Warrant conversions (in shares)     208,509          
Warrant Conversions 2,397,854   $ 20   2,397,834      
Other comprehensive income (loss) (65,615)           (55,999) (9,616)
Net income (loss) 651,749         769,983   (118,234)
Ending balance (in shares) at Jun. 30, 2024     75,484,567          
Ending balance, Treasury stock (in shares) at Jun. 30, 2024       (1,048,226)        
Ending balance at Jun. 30, 2024 256,849,488   $ 7,548 $ (12,025,137) 303,237,878 (34,514,318) 64,324 79,193
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Stock-based compensation (in shares)     271,772          
Stock-based compensation 6,416,378       6,416,378      
Warrant conversions (in shares)     100          
Warrant Conversions 1,150   $ 28   1,122      
Other comprehensive loss (53,656)           (42,682) (10,974)
Reclassification of change in fair value of debt (risk adjusted) upon related debt payoff 11,079           11,079  
Net income (loss) (5,284,811)         (5,125,055)   (159,756)
Ending balance (in shares) at Sep. 30, 2024     75,756,439          
Ending balance, Treasury stock (in shares) at Sep. 30, 2024       (1,048,226)        
Ending balance at Sep. 30, 2024 $ 257,939,628   $ 7,576 $ (12,025,137) 309,655,378 (39,639,373) 32,721 (91,537)
Beginning balance (in shares) at Dec. 31, 2024 0              
Beginning balance at Dec. 31, 2024 $ 0              
Series A Convertible Preferred Stock                
Issuance of series A convertible preferred stock (in shares) 5,000              
Issuance of series A convertible preferred stock $ 5,000,000              
Ending balance (in shares) at Mar. 31, 2025 5,000              
Ending balance at Mar. 31, 2025 $ 5,000,000              
Beginning balance (in shares) at Dec. 31, 2024   96,731,194 96,731,194          
Beginning balance at Dec. 31, 2024 $ 423,294,672   $ 10,133 $ (12,025,137) 494,064,113 (57,896,606) 0 (857,831)
Beginning balance, Treasury stock (in shares) at Dec. 31, 2024 (1,048,226)     (1,048,226)        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Common stock issuance transaction costs $ (470,068)       (470,065) (3)    
Stock-based compensation (in shares)     36,000          
Stock-based compensation 2,355,396   $ (456)   2,355,852      
Warrant conversions (in shares)     1,134,071          
Warrant Conversions 0   $ 113   (113)      
Net income (loss) 5,399,026         4,639,583   759,443
Ending balance (in shares) at Mar. 31, 2025     97,901,265          
Ending balance, Treasury stock (in shares) at Mar. 31, 2025       (1,048,226)        
Ending balance at Mar. 31, 2025 $ 430,579,026   $ 9,790 $ (12,025,137) 495,949,787 (53,257,026) 0 (98,388)
Beginning balance (in shares) at Dec. 31, 2024 0              
Beginning balance at Dec. 31, 2024 $ 0              
Ending balance (in shares) at Sep. 30, 2025 5,000              
Ending balance at Sep. 30, 2025 $ 5,000,000              
Beginning balance (in shares) at Dec. 31, 2024   96,731,194 96,731,194          
Beginning balance at Dec. 31, 2024 $ 423,294,672   $ 10,133 $ (12,025,137) 494,064,113 (57,896,606) 0 (857,831)
Beginning balance, Treasury stock (in shares) at Dec. 31, 2024 (1,048,226)     (1,048,226)        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Other comprehensive loss $ 0              
Reclassification of change in fair value of debt (risk adjusted) upon related debt payoff 0              
Net income (loss) $ 30,085,303              
Ending balance (in shares) at Sep. 30, 2025 97,704,800 104,430,882 104,430,882          
Ending balance, Treasury stock (in shares) at Sep. 30, 2025 (6,726,082)     (6,726,082)        
Ending balance at Sep. 30, 2025 $ 434,593,993   $ 10,443 $ (50,269,042) 513,709,228 (28,856,636) 0 0
Beginning balance (in shares) at Mar. 31, 2025 5,000              
Beginning balance at Mar. 31, 2025 $ 5,000,000              
Ending balance (in shares) at Jun. 30, 2025 5,000              
Ending balance at Jun. 30, 2025 $ 5,000,000              
Beginning balance (in shares) at Mar. 31, 2025     97,901,265          
Beginning balance at Mar. 31, 2025 430,579,026   $ 9,790 $ (12,025,137) 495,949,787 (53,257,026) 0 (98,388)
Beginning balance, Treasury stock (in shares) at Mar. 31, 2025       (1,048,226)        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Repurchase of common stock (in shares)       (5,081,477)        
Repurchase of common stock (35,051,781)     $ (35,051,781)        
Stock-based compensation (in shares)     53,206          
Stock-based compensation 3,486,828   $ 5   3,486,823      
Dividends declared on the Series A Convertible Preferred Stock (93,750)         (93,750)    
Other 1,940       1,933 7    
Net income (loss) 17,610,929         17,583,689   27,240
Ending balance (in shares) at Jun. 30, 2025     97,954,471          
Ending balance, Treasury stock (in shares) at Jun. 30, 2025       (6,129,703)        
Ending balance at Jun. 30, 2025 $ 416,533,192   $ 9,795 $ (47,076,918) 499,438,543 (35,767,080) 0 (71,148)
Ending balance (in shares) at Sep. 30, 2025 5,000              
Ending balance at Sep. 30, 2025 $ 5,000,000              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Transfer of non-controlling interest 0         (71,148)   71,148
Common stock issuance transaction costs (2,916,133)       (2,916,136) 3    
Repurchase of common stock (in shares)       (596,379)        
Repurchase of common stock (3,192,124)     $ (3,192,124)        
Stock-based compensation (in shares)     1,535,391          
Stock-based compensation 4,527,358   $ 154   4,527,204      
Warrant conversions (in shares)     4,687,332          
Warrant Conversions 11,049,193   $ 469   11,048,724      
Business acquisition (in shares)     253,688          
Business acquisition 1,610,918   $ 25   1,610,893      
Dividends declared on the Series A Convertible Preferred Stock (93,750)         (93,750)    
Other (9)         (9)    
Other comprehensive loss 0              
Reclassification of change in fair value of debt (risk adjusted) upon related debt payoff 0              
Net income (loss) $ 7,075,348         7,075,348    
Ending balance (in shares) at Sep. 30, 2025 97,704,800 104,430,882 104,430,882          
Ending balance, Treasury stock (in shares) at Sep. 30, 2025 (6,726,082)     (6,726,082)        
Ending balance at Sep. 30, 2025 $ 434,593,993   $ 10,443 $ (50,269,042) $ 513,709,228 $ (28,856,636) $ 0 $ 0